PTC Therapeutics Inc. buy Royal Bank of Canada
Start price
18.02.25
/
50%
€47.40
Target price
18.02.26
€60.28
Performance (%)
-11.81%
Price
15.08.25
€41.00
Summary
This prediction is currently active. The price of PTC Therapeutics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -11.81%. This prediction currently runs until 18.02.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| PTC Therapeutics Inc. | -3.302% | -3.302% |
| iShares Core DAX® | 0.648% | 1.259% |
| iShares Nasdaq 100 | -0.034% | 2.797% |
| iShares Nikkei 225® | 2.445% | 9.854% |
| iShares S&P 500 | 0.492% | 2.570% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at Royal Bank of Canada from $60.00 to $63.00. They now have an "outperform" rating on the stock.
Ratings data for PTCT provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€36.20
07.05.25
07.05.25
€51.13
07.05.26
07.05.26
15.47%
15.08.25
15.08.25
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€41.60
22.04.25
22.04.25
€56.55
22.04.26
22.04.26
-1.44%
15.08.25
15.08.25
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€49.60
03.12.24
03.12.24
€59.86
03.12.25
03.12.25
-15.73%
15.08.25
15.08.25